Masafumi Onodera

7.2k total citations · 2 hit papers
123 papers, 5.2k citations indexed

About

Masafumi Onodera is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Masafumi Onodera has authored 123 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 46 papers in Genetics and 45 papers in Immunology. Recurrent topics in Masafumi Onodera's work include Virus-based gene therapy research (38 papers), CAR-T cell therapy research (19 papers) and RNA Interference and Gene Delivery (15 papers). Masafumi Onodera is often cited by papers focused on Virus-based gene therapy research (38 papers), CAR-T cell therapy research (19 papers) and RNA Interference and Gene Delivery (15 papers). Masafumi Onodera collaborates with scholars based in Japan, United States and Germany. Masafumi Onodera's co-authors include Hiromitsu Nakauchi, Hideki Mochizuki, Hideo Ema, Hideki Taniguchi, Yohei Morita, Sanae Hamanaka, Shin Kaneko, Jun Ooehara, Ryō Yamamoto and K. Lenhard Rudolph and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Masafumi Onodera

122 papers receiving 5.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

2004 673 citations Masafumi Onodera et al. profile →
Clonal Analysis Unveils Self-Renewing Lineage-Restricted Progenitors Generated Directly from Hematopoietic Stem Cells

2013 499 citations Sanae Hamanaka, Masafumi Onodera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masafumi Onodera Japan	38	2.0k	1.8k	803	787	668	123	5.2k
Michelle L. Hermiston United States	31	2.3k 1.2×	1.6k 0.9×	923 1.1×	704 0.9×	692 1.0×	88	5.1k
Martha Kirby United States	42	1.9k 0.9×	2.1k 1.2×	800 1.0×	604 0.8×	587 0.9×	83	5.8k
Olivier Boyer France	43	1.9k 0.9×	1.6k 0.9×	772 1.0×	999 1.3×	354 0.5×	177	5.9k
Toshimitsu Matsui Japan	40	2.5k 1.3×	828 0.5×	1.0k 1.3×	492 0.6×	733 1.1×	220	5.9k
Nicolas Cagnard France	35	2.3k 1.2×	3.3k 1.9×	943 1.2×	791 1.0×	415 0.6×	83	7.2k
Oded Foreman United States	38	2.6k 1.3×	1.7k 0.9×	1.2k 1.5×	513 0.7×	212 0.3×	99	6.3k
Rafael Espinosa United States	35	2.7k 1.3×	916 0.5×	559 0.7×	777 1.0×	1.3k 1.9×	67	4.9k
Dietmar Pfeifer Germany	37	2.2k 1.1×	3.2k 1.8×	742 0.9×	733 0.9×	762 1.1×	128	6.6k
Anna Bigas Spain	40	4.1k 2.0×	1.2k 0.7×	980 1.2×	427 0.5×	635 1.0×	122	6.0k
Christian Schulz Germany	27	1.3k 0.7×	3.1k 1.7×	475 0.6×	240 0.3×	801 1.2×	58	5.6k

Countries citing papers authored by Masafumi Onodera

Since Specialization

Citations

This map shows the geographic impact of Masafumi Onodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Onodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Onodera more than expected).

Fields of papers citing papers by Masafumi Onodera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Onodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Onodera. The network helps show where Masafumi Onodera may publish in the future.

Co-authorship network of co-authors of Masafumi Onodera

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Onodera. A scholar is included among the top collaborators of Masafumi Onodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Onodera. Masafumi Onodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osumi, Tomoo, Hiroko Fukushima, Toru Uchiyama, et al.. (2022). Successful hematopoietic stem cell transplantation with reduced dose of busulfan for Omenn syndrome. PubMed. 5(3). 75–78. 1 indexed citations

Naiki, Yasuhiro, Mami Miyado, Reiko Horikawa, et al.. (2022). Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia. Human Gene Therapy. 33(15-16). 801–809. 10 indexed citations

Yamaguchi, Teruhide, Eriko Uchida, Takashi Okada, et al.. (2020). Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan. Human Gene Therapy. 31(19-20). 1043–1053. 10 indexed citations

Tsuchida, Naomi, Yohei Kirino, Masafumi Onodera, et al.. (2019). Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s disease. Arthritis Research & Therapy. 21(1). 137–137. 43 indexed citations

Hirai, Yukihiko, Hideto Chono, Junichi Mineno, et al.. (2019). Infectivity Assessment of Recombinant Adeno-Associated Virus and Wild-Type Adeno-Associated Virus Exposed to Various Diluents and Environmental Conditions. Human Gene Therapy Methods. 30(4). 137–143. 8 indexed citations

Yoshida, Wataru, Junko Tomikawa, Hiroshi Kimurâ, et al.. (2015). An Insulator Element Located at the Cyclin B1 Interacting Protein 1 Gene Locus Is Highly Conserved among Mammalian Species. PLoS ONE. 10(6). e0131204–e0131204. 7 indexed citations

Mori, Masaaki, Masafumi Onodera, Akira Morimoto, et al.. (2014). Palivizumab Use In Japanese Infants And Children With Immunocompromised Conditions. The Pediatric Infectious Disease Journal. 33(11). 1183–1185. 12 indexed citations

Tornack, Julia, Andreas Grützkau, Joachim R. Grün, et al.. (2013). Ectopic Runx1 Expression Rescues Tal-1-Deficiency in the Generation of Primitive and Definitive Hematopoiesis. PLoS ONE. 8(7). e70116–e70116. 2 indexed citations

Kawai, Toshinao, Nobuyuki Watanabe, Katsuhiro Arai, et al.. (2013). Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease. Clinical Immunology. 147(2). 122–128. 22 indexed citations

10.

Kawano, Yoshinaga, Jun Nakae, Nobuyuki Watanabe, et al.. (2012). Loss of Pdk1-Foxo1 Signaling in Myeloid Cells Predisposes to Adipose Tissue Inflammation and Insulin Resistance. Diabetes. 61(8). 1935–1948. 53 indexed citations

11.

Kawai, Toshinao, et al.. (2011). Osteomyelitis due to trimethoprim/sulfamethoxazole-resistant Edwardsiella tarda infection in a patient with X-linked chronic granulomatous disease. Infection. 39(2). 171–173. 21 indexed citations

12.

Onodera, Masafumi, Yoshitaka Miyagawa, Ban Sato, et al.. (2009). Kinetics and Effect of Integrin Expression on Human CD34 ⁺ Cells During Murine Leukemia Virus-Derived Retroviral Transduction with Recombinant Fibronectin for Stem Cell Gene Therapy. Human Gene Therapy. 20(7). 777–783. 3 indexed citations

13.

Tamase, Akira, Teruyuki Muraguchi, Kazuhito Naka, et al.. (2009). Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proceedings of the National Academy of Sciences. 106(40). 17163–17168. 72 indexed citations

14.

Matsunari, Hitomi, Masafumi Onodera, Norihiro Tada, et al.. (2008). Transgenic-Cloned Pigs Systemically Expressing Red Fluorescent Protein, Kusabira-Orange. Cloning and Stem Cells. 10(3). 313–324. 47 indexed citations

15.

Hamanaka, Sanae, Shin Kaneko, Makoto Otsu, et al.. (2008). A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells. The Journal of Gene Medicine. 10(9). 965–971. 16 indexed citations

16.

Nabekura, Tsukasa, Toshiro Nagasawa, Hiromitsu Nakauchi, & Masafumi Onodera. (2007). An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2. Cancer Immunology Immunotherapy. 57(5). 611–622. 11 indexed citations

17.

Sasaki, Takeshi, Hiroaki Ikeda, Masayoshi Satō, et al.. (2006). Antitumor activity of chimeric immunoreceptor gene‐modified Tc1 and Th1 cells against autologous carcinoembryonic antigen‐expressing colon cancer cells. Cancer Science. 97(9). 920–927. 9 indexed citations

18.

Ueno, Takamasa, Mamoru Fujiwara, Hiroko Tomiyama, Masafumi Onodera, & Masafumi Takiguchi. (2004). Reconstitution of anti‐HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV‐specific αβ TCR genes. European Journal of Immunology. 34(12). 3379–3388. 19 indexed citations

19.

Onodera, Masafumi & Yukio Sakiyama. (2000). Adenosine deaminase deficiency as the first target disorder in gene therapy. Expert Opinion on Investigational Drugs. 9(3). 543–549. 3 indexed citations

20.

Onodera, Masafumi, David M. Nelson, Akihiro Yachie, et al.. (1998). Development of Improved Adenosine Deaminase Retroviral Vectors. Journal of Virology. 72(3). 1769–1774. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact